Company Profile
Iksuda Therapeutics Limited
06433234•Private Limited With Share Capital
Get Full Access
21/11/2007
18 years
5
41
72110
high risk
Company Overview
Registration, classification & business activity
Iksuda Therapeutics Limited (06433234) is a private limited with share capital incorporated on 21/11/2007 (18 years old) and registered in newcastle upon tyne, NE45BX. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Through our highly experienced adc research & development team, we are building a pipeline of class-leading adcs with superior therapeutic index (ti) for difficult-to-treat cancers.our approach is to develop the best adc for any given target or tumor sub-type rather than 'technology-driven adcs'. al...
Financial Overview
£7.82M
£43.40M
£-35.59M
£4.90M
£1.07M
Key Metrics
41
Employees
5
Directors
41
Shareholders
6
Patents
Board of Directors
Innovate Grants
This company received a grant of £56318.0 for Improving The Therapeutic Window Of Glycosylated Drug Classes And The Development Of A Novel, Rapid, High Throughput Analytical Methodology To Streamline The Drug Development Pathway.. The project started on 01/08/2015 and ended on 31/07/2016.
This company received a grant of £756165.0 for Improving The Therapeutic Index Of Antibody Drug Conjugates Through Precision Conjugate Design. The project started on 01/02/2017 and ended on 30/11/2018.
Import / Export
Risk Assessment
high risk
International Score
Future Factor
emerging
Performance Rating